Novartis looks at possible venture at Dubai Healthcare City
Novartis Pharma Services has begun to investigate potential collaborations in the areas of medical research, diagnostic services and education at the Dubai Healthcare City (DHCC).
Novartis General Manager Stewart Fairbairn, along with Regional Head of Arabian Gulf operations, Roger A. Bassoul and Head of Marketing, Elisabeth MacGillivray arrived in Dubai and met with Chairman of the Board of Dubai Healthcare City, Saeed Al-Muntafiq, and DHCC CEO, Adel Saeed Al-Shamsi.
They discussed potential partnership between the two institutions and how facilities at DHCC could possibly be utilized by Novartis in its focus areas.
Al Muntafiq welcomed the interest from Novartis saying that it has been the endeavor of DHCC to find partners who are highly respected in the world for their technology, research and product and services.
Novartis is a leading global medical institution. It was created in 1996 from the merger of the Swiss companies, Ciba and Sandoz. By 2002, the Group's businesses achieved sales of $20.9 billion and a net income of $4.7 billion. The Group invested approximately $2.8 billion in research and development. — (menareport.com)
© 2003 Mena Report (www.menareport.com)